Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning

Summary

Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning is a clinical trial^[1].

Key Facts

• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning is in the country of United States^[2].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's instance of is recorded as clinical trial^[3].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's start time is recorded as +2012-04-30T00:00:00Z^[4].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's end time is recorded as +2019-04-30T00:00:00Z^[5].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's sponsor is recorded as The University of Texas MD Anderson Cancer Center^[6].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's main subject is recorded as methotrexate-associated lymphoproliferation^[7].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's main subject is recorded as stem cell transplantation for articular cartilage repair^[8].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's main subject is recorded as lymphoma^[9].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's main subject is recorded as multiple myeloma^[10].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's main subject is recorded as leukemia^[11].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's number of participants is recorded as {'unit': '1', 'amount': '+200'}^[12].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's title is recorded as Phase II Study of Timed Sequential Busulfan in Combination With Fludarabine in Allogeneic Stem Cell Transplantation^[13].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+5'}^[14].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's ClinicalTrials.gov ID is recorded as NCT01572662^[15].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}^[16].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's research intervention is recorded as methotrexate^[17].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's research intervention is recorded as fludarabine phosphate^[18].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's research intervention is recorded as tacrolimus^[19].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's research intervention is recorded as busulfan^[20].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's research intervention is recorded as vidarabine^[21].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's research intervention is recorded as lenograstim^[22].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's clinical trial phase is recorded as phase II clinical trial^[23].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's research site is recorded as The University of Texas MD Anderson Cancer Center^[24].
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning's study type is recorded as interventional study^[25].